Dudediligence.

Cadrenal Therapeutics, Inc

CVKDNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$753,918

11 notices · 123,070 sh

Oct 2025 to Oct 2026

Reported ·

$585,500

28 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

25 of 28 reported sales carry the 10b5-1 box. Together they are 2.86% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-15: Quang X. Pham, Form 1442026-05-11: Quang X. Pham, Form 1442025-12-29: MATTHEW K SZOT, Form 1442025-10-27: MATTHEW SZOT, Form 1442025-10-27: Quang X. Pham, Form 1442025-10-24: MATTHEW SZOT, Form 1442025-10-24: Quang X. Pham, Form 1442025-10-13: MATTHEW SZOT, Form 1442025-10-13: Quang X. Pham, Form 1442025-10-09: MATTHEW SZOT, Form 1442025-10-09: Quang X. Pham, Form 1442025-10-09: Szot Matthew K, sold2025-10-09: Pham Quang X, sold2025-10-24: Pham Quang X, sold2025-10-24: Szot Matthew K, sold2025-12-29: Szot Matthew K, sold2026-05-11: Pham Quang X, sold2026-05-22: Pham Quang X, sold2026-05-29: Pham Quang X, sold2026-06-03: Pham Quang X, sold2026-06-08: Pham Quang X, sold2026-06-11: Pham Quang X, sold2026-06-16: Pham Quang X, sold2026-06-22: Pham Quang X, sold
under a ▼ salesize is dollars

Form 144 notices, newest first

2026-06-15Quang X. Pham, Chairman, CEO and Interim CFO$148,400
40,000 shplan 2025-09-23144 ↗
Form 4, 2026-06-18: sold 4,126 at $3.18 Form 4 ↗
2026-05-11Quang X. Pham, Chairman, CEO and Interim CFO$348,600
60,000 shplan 2025-09-23144 ↗
Form 4, 2026-05-29: sold 12,763 at $5.44 Form 4 ↗
2025-12-29MATTHEW K SZOT, Chief Financial Officer$73,604
9,933 shplan 2025-09-18144 ↗
Form 4, 2025-12-31: sold 9,933 at $6.97 Form 4 ↗
2025-10-27MATTHEW SZOT, Chief Financial Officer$25,442
1,800 shplan 2025-05-09no Form 4 on file144 ↗
2025-10-27Quang X. Pham, Chairman, CEO and Interim CFO$18,397
1,315 shplan 2025-05-09no Form 4 on file144 ↗
2025-10-24MATTHEW SZOT, Chief Financial Officer$24,786
1,800 shplan 2025-05-09144 ↗
Form 4, 2025-10-28: sold 3,600 at $13.99 Form 4 ↗
2025-10-24Quang X. Pham, Chairman, CEO and Interim CFO$15,841
1,129 shplan 2025-05-09144 ↗
Form 4, 2025-10-28: sold 2,444 at $14.01 Form 4 ↗
2025-10-13MATTHEW SZOT, Chief Financial Officer$24,516
1,800 shplan 2025-05-09no Form 4 on file144 ↗
2025-10-13Quang X. Pham, Chairman, CEO and Interim CFO$25,470
1,800 shplan 2025-05-09no Form 4 on file144 ↗
2025-10-09MATTHEW SZOT, Chief Financial Officer$23,634
1,693 shplan 2025-05-09144 ↗
Form 4, 2025-10-14: sold 3,493 at $14.03 Form 4 ↗
2025-10-09Quang X. Pham, Chairman, CEO and Interim CFO$25,228
1,800 shplan 2025-05-09144 ↗
Form 4, 2025-10-14: sold 3,600 at $14.09 Form 4 ↗